CIDRAP newsletters options
Giving the second dose at 3 months resulted in up to 47% greater protection than giving it at 6 weeks.
Tedros urges vaccine companies to prioritize COVAX contracts and for high-income countries to avoid signing new contracts that deplete the global supply.
Seven poultry workers at a plant in southern Russia are infected; the nation first reported the strain in poultry last year.
The Australian government late last week released a One Health Master Action Plan (OHMAP) to support the country's 2o20 antimicrobial resistance (AMR) strategy.
People who received their flu vaccine were less likely to test positive for COVID-19, and if they were infected with the virus, they were less likely to need hospitalization, mechanical ventilation, or a longer hospital stay, according to a study published today in the American Journal of Infection Control.
New studies and regulatory requests from Pfizer could pave the way for more pregnant women to be vaccinated and more developing nations to receive vaccine.
One of the studies is based on psychiatric assessment after COVID-19 emergency care, and the other is based on a US web survey of adults.
G7 leaders pledge more than $4 billion more to COVAX; deliveries to lower-resource nations begin soon.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A new study conducted in Sweden provides evidence that hospital wastewater selects for multidrug-resistant strains of bacteria while killing antibiotic-sensitive bacteria.
Provincial health officials in the Democratic Republic of the Congo's (DRC's) North Kivu province yesterday reported two more Ebola cases, one of them more than 90 miles from Butembo, the main epicenter, according to Reuters.
The new cases raise the outbreak total to six, with the number of deaths remaining at two. One of the new patients is from Katwa, about 6 miles from Butembo. The other is from Manguredjipa, about 93 miles away.
More than 20.5 million years of life may have been lost during the COVID-19 pandemic, according to a Scientific Reports study published yesterday. The study also reports that, compared with the median mortality rate of the seasonal flu, COVID-19 deaths may be two to nine times higher.
The WHO is deploying 100 staff and, for Guinea, has released $1.25 million to support local control efforts.
A single high dose did not affect hospital and ICU stay or the need for a ventilator.
Also, the White House says it will spend $650 million to expand testing for schools and congregate settings.
Elsewhere, the WHO launches a plan to battle COVID-19 in 2021; it needs $2 billion to meet its 6 goals.
Lab studies point to lower protection against the variant first identified in South Africa.
The AMR Action Fund announced today the appointment of a new chief executive officer and more than $140 million in investments from the Boehringer Ingleheim Foundation, The European Investment Bank, and the Wellcome Trust.
An analysis by Canadian researchers suggests that a single dose of the Pfizer-BioNTech COVID-19 vaccine is highly efficacious, according to a letter published yesterday in the New England Journal of Medicine (NEJM).
The B117 variant has now been detected in 94 countries, with local transmission occurring in 47.
The authors conclude that pregnant women should be broadly prioritized for COVID-19 vaccine allocation.
